Our Team

Carlos Singer, M.D.

Professor of Neurology
Faculty

Biography

Dr. Carlos Singer is Professor of Neurology at the Miller School of Medicine of the University of Miami. He served as Chief of Movement Disorders from 2002 to 2020 and was the Founding Director of the UM Parkinson Foundation Center of Excellence. He currently serves as the Co-Director of the UM Parkinson Foundation and Co-Director of the UM Huntington Disease Society of America Center of Excellence. He received his medical degree from the Central University of Venezuela. This was followed by training in Internal Medicine at the University of Pittsburg and in Neurology at the Albert Einstein College of Medicine Affiliated Hospitals. Dr. Singer received additional training in Electromyography and in Movement Disorders at the University of Miami. Dr. Singer is board certified in both Internal Medicine and Neurology. He has been a member of the faculty of the Department of Neurology of the Miller School of Medicine/University of Miami since 1989. 

Dr. Singer chaired the working group on "Non-Motor Manifestations of Parkinson Disease” of the Parkinson Study Group. He served as a member of the Education Committee of the Pan-American Section of the Movement Disorders Society from 2017-2021.  He is a member of the American Academy of Neurology, the American Neurological Association, the International Association of Parkinsonism and Related Disorders (IAPRD), the Movement Disorders Society, the Parkinson Study Group, the Huntington Study Group and the Dystonia Study Group. He established the first Botulinum Toxin Treatment Program for Neurological Disorders in Florida in 1990.   Dr. Singer was honored in 2011 with the Faculty Hero Award by the University of Miami Medical Group for his patient-centered service and in 2024 with the Excellence in Service Award by University of Miami.  He has served in the editorial board of the Journal of Neurological Sciences. Dr. Singer has published more than 200 articles in the field of Movement disorders and Co-Edited the February 2020 issue on “Parkinson Disease” of the Clinics in Geriatric Medicine published by Elsevier.

Sustain our mission to enhance lives and outcomes through research

As we work to improve patient quality of life — for their entire lifespan — we seek partners to catapult our progress. With your philanthropic investment, we can expand the breadth and depth of our efforts in three critical areas: research, clinical care and education and training.

Support Us